Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IIIA Stage Non-small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT01345851
What this trial is testing

Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerLarge Cell Lung Cancer+6 more
Jonsson Comprehensive Cancer Center 29
Post-approval studies (Phase 4)Study completedNCT00686322
What this trial is testing

Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)

Who this might be right for
Non-small-cell Lung Cancer
Taipei Veterans General Hospital, Taiwan 6
Early research (Phase 1)Active Not RecruitingNCT04073745
What this trial is testing

Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaPositive Surgical MarginResected Mass+7 more
Roswell Park Cancer Institute 50
Testing effectiveness (Phase 2)Study completedNCT00103051
What this trial is testing

Gemcitabine, Cisplatin, and Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)WithdrawnNCT04989283
What this trial is testing

Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage IIB Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+1 more
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT04976296
What this trial is testing

MRD Monitoring in Lung Cancer After Resection

Who this might be right for
Lung Cancer
Guangdong Provincial People's Hospital 300
Early research (Phase 1)Study completedNCT00010023
What this trial is testing

Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Cancer
NYU Langone Health
Not applicableEnded earlyNCT00424138
What this trial is testing

FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy

Who this might be right for
Lung Cancer
American College of Radiology Imaging Network 96
Testing effectiveness (Phase 2)Study completedNCT00280735
What this trial is testing

Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLC

Who this might be right for
Lung Cancer
UNC Lineberger Comprehensive Cancer Center 75
Large-scale testing (Phase 3)Study completedNCT00030771
What this trial is testing

Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients

Who this might be right for
Lung Cancer
Swiss Cancer Institute 232
Large-scale testing (Phase 3)Study completedNCT00003317
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 480
Large-scale testing (Phase 3)Ended earlyNCT00234468
What this trial is testing

Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC

Who this might be right for
Non Small Cell Lung Carcinoma
AstraZeneca 490
Not applicableStudy completedNCT00653250
What this trial is testing

Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Vanderbilt-Ingram Cancer Center 22
Not applicableLooking for participantsNCT05010109
What this trial is testing

Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation

Who this might be right for
Locally Advanced Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+2 more
M.D. Anderson Cancer Center 100
Large-scale testing (Phase 3)Study completedNCT00004011
What this trial is testing

S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 354
Early research (Phase 1)Study completedNCT00005630
What this trial is testing

Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT00676507
What this trial is testing

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Who this might be right for
Lung NeoplasmCarcinoma Non-small Cell Lung Cancer Stage IIIACarcinoma Non-small Cell Lung Cancer Stage IIIB+1 more
NovaRx Corporation 532
Testing effectiveness (Phase 2)Study completedNCT00198367
What this trial is testing

Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Hospices Civils de Lyon 120
Very early researchStudy completedNCT01781741
What this trial is testing

Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+1 more
Roswell Park Cancer Institute 10
Testing effectiveness (Phase 2)Study completedNCT00081302
What this trial is testing

Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group
Next Page